World Wires · story 25161 · unverified · 1 source(s)

Caribou Biosciences to Evaluate Strategic Alternatives

-- Company to evaluate strategic alternatives to maximize stockholder value -- -- Caribou plans to discontinue vispa-cel and CB-011 allogeneic CAR-T cell t

Open in the desk

Coverage

• Caribou Biosciences to Evaluate Strategic Alternatives GlobeNewswire: public companies · tier D · clear net · 2026-10-06 20:05 UTC

What this site indexes